| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 49 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 49 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 49 |
| 3 | FILGRASTIM | 26 |
| 4 | FLUDARABINE PHOSPHATE | 26 |
| 5 | TACROLIMUS | 26 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 24 |
| 7 | TACROLIMUS OINTMENT 0.1% | 24 |
| 8 | MELPHALAN HYDROCHLORIDE | 22 |
| 9 | MELPHALAN | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETIBEGLOGENE AUTOTEMCEL | 2 | 0.0357 |
| 1 | EXAGAMGLOGENE AUTOTEMCEL | 1 | 0.0200 |
| 2 | NITAZOXANIDE | 2 | 0.0057 |
| 3 | PALIFERMIN | 2 | 0.0051 |
| 4 | PLERIXAFOR | 6 | 0.0040 |
| 5 | SARGRAMOSTIM | 6 | 0.0035 |
| 6 | IBRITUMOMAB TIUXETAN | 4 | 0.0026 |
| 7 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 6 | 0.0025 |
| 8 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 9 | DECITABINE | 7 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 2 | 0.0051 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 6 | 0.0040 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 6 | 0.0025 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 5 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Antiprotozoal [EPC] | 3 | 0.0003 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |
| 8 | Alkylating Drug [EPC] | 61 | 0.0003 |
| 9 | Leukocyte Growth Factor [EPC] | 34 | 0.0002 |